TY - JOUR
T1 - Advances in Multimodality Imaging in Cardio-Oncology
T2 - JACC State-of-the-Art Review
AU - ACC Cardio-Oncology and the ACC Imaging Councils
AU - Baldassarre, Lauren A.
AU - Ganatra, Sarju
AU - Lopez-Mattei, Juan
AU - Yang, Eric H.
AU - Zaha, Vlad G.
AU - Wong, Timothy C.
AU - Ayoub, Chadi
AU - DeCara, Jeanne M.
AU - Dent, Susan
AU - Deswal, Anita
AU - Ghosh, Arjun K.
AU - Henry, Mariana
AU - Khemka, Abhishek
AU - Leja, Monika
AU - Rudski, Lawrence
AU - Villarraga, Hector R.
AU - Liu, Jennifer E.
AU - Barac, Ana
AU - Scherrer-Crosbie, Marielle
N1 - Publisher Copyright:
© 2022 American College of Cardiology Foundation
PY - 2022/10/18
Y1 - 2022/10/18
N2 - The population of patients with cancer is rapidly expanding, and the diagnosis and monitoring of cardiovascular complications greatly rely on imaging. Numerous advances in the field of cardio-oncology and imaging have occurred in recent years. This review presents updated and practical approaches for multimodality cardiovascular imaging in the cardio-oncology patient and provides recommendations for imaging to detect the myriad of adverse cardiovascular effects associated with antineoplastic therapy, such as cardiomyopathy, atherosclerosis, vascular toxicity, myocarditis, valve disease, and cardiac masses. Uniquely, we address the role of cardiovascular imaging in patients with pre-existing cardiomyopathy, pregnant patients, long-term survivors, and populations with limited resources. We also address future avenues of investigation and opportunities for artificial intelligence applications in cardio-oncology imaging. This review provides a uniform practical approach to cardiovascular imaging for patients with cancer.
AB - The population of patients with cancer is rapidly expanding, and the diagnosis and monitoring of cardiovascular complications greatly rely on imaging. Numerous advances in the field of cardio-oncology and imaging have occurred in recent years. This review presents updated and practical approaches for multimodality cardiovascular imaging in the cardio-oncology patient and provides recommendations for imaging to detect the myriad of adverse cardiovascular effects associated with antineoplastic therapy, such as cardiomyopathy, atherosclerosis, vascular toxicity, myocarditis, valve disease, and cardiac masses. Uniquely, we address the role of cardiovascular imaging in patients with pre-existing cardiomyopathy, pregnant patients, long-term survivors, and populations with limited resources. We also address future avenues of investigation and opportunities for artificial intelligence applications in cardio-oncology imaging. This review provides a uniform practical approach to cardiovascular imaging for patients with cancer.
KW - cardio-oncology
KW - imaging
KW - multimodality
UR - http://www.scopus.com/inward/record.url?scp=85139812383&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139812383&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2022.08.743
DO - 10.1016/j.jacc.2022.08.743
M3 - Review article
C2 - 36229093
AN - SCOPUS:85139812383
SN - 0735-1097
VL - 80
SP - 1560
EP - 1578
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 16
ER -